BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Rudwaleit M, Navarro-Compán V, Russ H, Panni T, Filippi E, Nassab MH, Liu-Leage S, Goëb V, Ciccia F, Dudler J

DOI: 10.1093/rap/rkaf012
Published: 2025
Container: Rheumatology advances in practice
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rap/rkaf012,
  title = {BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.},
  author = {Rudwaleit M and Navarro-Compán V and Russ H and Panni T and Filippi E and Nassab MH and Liu-Leage S and Goëb V and Ciccia F and Dudler J},
  year = {2025},
  journal = {Rheumatology advances in practice},
  doi = {10.1093/rap/rkaf012},
  url = {https://doi.org/10.1093/rap/rkaf012}
}

RIS

TY  - JOUR
TI  - BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.
AU  - Rudwaleit M
AU  - Navarro-Compán V
AU  - Russ H
AU  - Panni T
AU  - Filippi E
AU  - Nassab MH
AU  - Liu-Leage S
AU  - Goëb V
AU  - Ciccia F
AU  - Dudler J
PY  - 2025
JO  - Rheumatology advances in practice
DO  - 10.1093/rap/rkaf012
UR  - https://doi.org/10.1093/rap/rkaf012
ER  -

APA

M, R., V, N., H, R., T, P., E, F., MH, N., S, L., V, G., F, C., & J, D. (2025). BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.. Rheumatology advances in practice. https://doi.org/10.1093/rap/rkaf012

Source records

pubmed · retrieved 2026-09-26T00:05:42.804Z